Skip to main
OHI
OHI logo

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 33%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc. has revised its forecast for 2025, increasing its funds from operations (FFO) estimate to $2.81 per share, up from $2.78, primarily due to an anticipated rise in investment volume. Additionally, the normalized FFO estimate has been raised to $2.95 per share from $2.89, after excluding various non-recurring items, indicating a positive trend in operational performance. Furthermore, the stock has demonstrated a robust year-to-date performance of 12%, significantly outperforming its benchmark, and is currently trading near the upper end of its 10-year valuation range, suggesting strong investor confidence.

Bears say

Omega Healthcare Investors Inc faces a negative outlook primarily due to ongoing challenges faced by its operators, which hinder the company's ability to improve its financial performance and valuation. Despite a slight increase in the adjusted Funds From Operations (FFO) estimate for 2026, moving from $3.13 per share to $3.22 per share, this figure remains above the broader consensus of $3.10 per share, indicating potential concerns regarding operational sustainability. The persistent difficulties within the operator segment and the company's relative valuation metrics suggest caution for future investment considerations.

OHI has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 33% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 9 analysts, OHI has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.